This research paper evaluates the HeartConnect model of care, which aims for greater collaboration between general practitioners and cardiologists.

Problems affecting the female breast are diverse, affect all life stages, and require general practitioners to manage acute, chronic and preventive healthcare issues.

Overweight and obesity is the leading disease burden risk factor in Australia. In this issue we explore the dietary, pharmacological and surgical management options, and the systems we work within.

Australia’s outdated definition of obesity likely hinders management and contributes to the observed gap between clinical guidelines and current practice.

This paper provides a commentary on four popular diets highlighting potential considerations, advantages and disadvantages.

Obesity is prevalent and tertiary prevention of the complications of obesity can be provided through publicly funded obesity management clinics as well as private obesity or general practice clinics.

Conventionally prescribed for treatment of diabetes, glucagon-like peptide-1 receptor agonists are also increasingly used in weight management as the prevalence of obesity rises.

This article provides an update on pharmacotherapy for the management of overweight and obesity.

This paper evaluates the efficacy, indications, outcomes and long-term considerations of bariatric surgery.

These questions are based on the Focus articles in this issue.

Consults involving obesity and weight management can be complex, often requiring a biopsychosocial approach and consideration of the stigma from both the general population and within healthcare.

Readers express their opinions on published articles and topics of interest.

The aim of this review is to draw attention to a preventable childhood condition, detailing the clinical presentation, diagnostic pathway and management.

A case presentation of a patient with fatigue and chronic anaemia.

This paper describes the overall number of prescriptions and unique medicines dispensed and costs borne by a cohort of patients treated with lipid-lowering therapy.